Shuimu BioSciences

Shuimu BioSciences, established in 2017, is based at 1 Broadway, 5th floor, Cambridge, MA 02142, United States. The company specializes in a cryo-EM platform for drug discovery, offering a range of services including tomography, cryo-EM SPA, cryo-EM characterization, data collection, protein production, and MicroED. Since its inception, Shuimu BioSciences has delivered high-quality cryo-EM and microED structures to over 400 clients. The company is equipped with eight state-of-the-art 300kV cryo-EM instruments and has achieved a highest resolution of 1.4Å in cryo-EM. Shuimu BioSciences has strategic partnerships with industry leaders such as Thermo Fisher Scientific and NVIDIA. Additionally, they offer membership plans that provide benefits like exclusive content access and discounts on services. The company has also developed unique toolkits, including GraFuture™ and modelSMART, to enhance cryo-EM structure determination.